This section provides news and developments at member companies.
NuView Life Sciences is a biotechnology company based in Park City, Utah that is focused on precision cancer diagnostics and therapeutics improving patient outcomes and reducing healthcare costs. Founded in 2005, their […]
Nanostics Inc. is a medical device and biotechnology company based in Alberta, Canada. They are focused on developing a highly accurate test to predict clinically significant prostate cancer. Their core technology, ClarityDX, […]
Minomic, a Sydney-based diagnostic company, has developed an in vitro diagnostic test for the early detection of prostate cancer. Their product, MiCheck®, is a blood test that uses their patented monoclonal antibody […]
Travera’s new technology can predict how patients will respond to hundreds of different drugs or drug combinations before the patients even take the drugs. Their new measurement tool, the Suspended Microchannel Resonator […]
Soligenix is a late-stage biopharmaceutical company focused on developing and commercializing products to treat rare diseases where there is currently an unmet medical need. Soligenix is a biotherapeutic business segment dedicated to […]
NCI Press Release August 15, 2018 Women who had cancer cells detected in their blood 5 years after a breast cancer diagnosis were 13 times more likely to have their cancer return […]
ALISO VIEJO, Calif. & SAVANNAH, Ga.–(BUSINESS WIRE)–Clarient, Inc. (Nasdaq: CLRT), a premier anatomic pathology and molecular testing services resource for pathologists, oncologists, and the pharmaceutical industry, and Health Discovery Corporation (HDC) (OTCBB: […]
Company Successfully Transfers T-Cell Receptor Genetic Material into Human Hematopoietic Stem Cells ImmunoCellular Therapeutics, Ltd., a Los Angeles-based clinical stage immuno-oncology company, has achieved an important milestone toward initiating pre-clinical trials of […]
